July 23 (Reuters) - Novo Nordisk's
weight-loss drug Wegovy has secured the UK regulator's approval
for its use to reduce the risk of overweight and obese adults
suffering serious heart problems or strokes, the agency said on
Tuesday.
(Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)